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Relationship between health-related quality of life,
comorbidities and acute health care utilisation, in
adults with chronic conditions
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and Wen Kwang Lim1,5
Abstract
Background: There is increased interest in developing multidisciplinary ambulatory care models of service delivery
to manage patients with complex chronic diseases. These programs are expensive and given limited resources it is
important that care is targeted effectively. One potential screening strategy is to identify individuals who report the
greatest decrement in health related quality of life (HRQoL) and thus greater need. The aim of this study was to
explore the relationship between HRQoL, comorbid conditions and acute health care utilisation.
Methods: A prospective, longitudinal cohort design was used to evaluate the impact of HRQoL on acute care
utilisation rates over three-years of follow-up. Participants were enrolled in chronic disease management programs run
by a metropolitan health service in Australia. Baseline data was collected from 2007–2009 and follow-up data until
2012. Administrative data was used to classify patients’ primary reasons for enrolment, number of comorbidities
(Charlson Score) and presentations to acute care. At enrolment, HRQoL was measured using the Assessment of
Quality of Life (AQoL) instrument, for analysis AQoL scores were dichotomised at two standard deviations below
the population norm.
Results: There were 1999 participants (54 % male) with a mean age of 63 years (range 18–101), enrolled in the
study. Participants’ primary health conditions at enrolment were: diabetes 915 (46 %), chronic respiratory disease 463
(23 %), cardiac disease 260 (13 %), peripheral vascular disease, and 181 (9 %) and aged care 180 (9 %). At 1-year
multivariate logistic regression models demonstrated that AQOL utility score was not predictive of acute care
presentations after adjusting for comorbidities. Over 3-years an AQoL utility score in the lowest quartile was
predictive of both ED presentation (OR 1.58, 95 % CI, 1.16–2.13, p = 0.003) and admissions (OR 1.67, 95 % CI.1.21
to 2.30, p = 0.002) after adjusting for differences in age and comorbidities.
Conclusion: This study found that both HRQoL and comorbidities were predictive of subsequent acute care
attendance over 3-years of follow-up. At 1-year, comorbidities was a better predictor of acute care representation than
HRQoL. To maximise benefits, programs should initially focus on medical disease management, but subsequently
switch to strategies that enhance health independence and raise HRQoL.
Keywords: Health-related quality of life, Acute healthcare utilisation, Chronic disease management, Ambulatory care
sensitive conditions, Chronic obstructive pulmonary disease, Chronic heart failure, Diabetes, Aged care
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Background
In response to the worldwide growth in the prevalence of
chronic disease, there is increased interest in developing
ambulatory models of care that will improve patient out-
comes and minimise demand on emergency departments
and acute inpatient services [1–3]. Over the past 15 years
Australian health authorities have funded a wide range of
programs to improve the management of patients with
chronic disease that requires acute care [4]. These ini-
tiatives typically identify patients following acute care
attendance for conditions such as chronic heart failure
(CHF), chronic obstructive lung disease (COPD), or
diabetes and offer interventions such as: exercise re-
habilitation, self-management education and support,
community-outreach and case-management services.
To ensure effective use of limited resources it is im-
portant that these programs enrol those patients who
will benefit the most and/who are at high risk of re-
attendance for acute care management. One of the
challenges clinicians therefore face is identifying these
high-risk individuals, so that the programs can be tar-
geted effectively to those patients with the highest level
of need [5].
Internationally there have been a range of attempts at
developing prediction algorithms that identify patients at
high risk of early acute care readmission who would
benefit from increased ambulatory care services post dis-
charge [5, 6]. For example, a US study found that age,
sex, ethnicity, number of previous admissions, and clin-
ical condition were indicators of readmission risk and
that those scoring ≥80 (on a 0–100 scale) had an 84 %
likelihood of being readmitted over the following 12-
months [7]. Although numerous risk stratification tools
have been developed and validated for individual disease
groups [8–11] there is a lack of generic measures that
can be used across different conditions, ages and complex-
ity of disease to predict individuals at high risk of readmis-
sion to acute care. Many risk stratification instruments
focus on measures of disease severity and fail to measure
the patient factors that modify subsequent health care util-
isation behaviour [12–14]. Furthermore, identification of
individuals with advanced disease who may benefit from
advance care planning or more palliative approaches to
disease management is reportedly poor [15]. To address
these questions this study was undertaken to evaluate
whether a generic measure of health related quality of life
(HRQoL) was predictive of subsequent acute health care
utilisation in a heterogeneous patient group [16].
The Northern Alliance Hospital Admission Program
(NA-HARP) service provides care to a socio-economically
disadvantaged population living in the northern metropol-
itan region of Melbourne, Australia [16, 17]. The service
offers multidisciplinary disease management and short-
term care coordination to individuals with chronic disease
(ischaemic heart disease (IHD), CHF, COPD, asthma, dia-
betes, peripheral vascular disease (PVD) and chronic
wounds) and older adults with complex aged care related
needs [4]. The aim of this analysis was to describe the
HRQoL of adults enrolled in the NA-HARP programs
and to explore the relationship between HRQoL, comor-
bid conditions and acute health care utilisation over the
three years following enrolment.
Methods
Setting
The NA-HARP program provides multidisciplinary
case-management, exercise rehabilitation, disease self-
management education and support, ambulatory care
management of complex wounds and care coordination
for patients with complex psychosocial needs. The multi-
disciplinary team includes: specialist physicians, physio-
therapy, health psychology, occupational therapy, social
workers and specialist nurse consultants. The program in-
cludes separate streams of care for patients with (1)
chronic respiratory diseases (asthma and COPD), (2) car-
diac conditions (IHD and CHF), (3) diabetes, (4) periph-
eral vascular disease and complex wounds, and (5)
complex psychosocial and aged care needs.
Eligibility for the program was patients with one or
more chronic conditions that placed them at high risk of
emergency department attendance or acute care admis-
sion [2–4]. Although referral to the program was accepted
from both primary and acute health care providers, prior-
ity was given to patients who had been recently discharged
from acute care. At enrolment clinicians within each
stream conducted a comprehensive needs assessment and
developed a care-plan which included a suite of interven-
tions tailored to the individuals’ needs.
Study design
A prospective, longitudinal cohort design was used to
evaluate whether a measure of HRQoL obtained at en-
rolment was predictive of acute care re-attendance over
a three year follow-up period. Baseline data was col-
lected from September 2007–2009 and follow-up data
was obtained until December 2012. This project was ap-
proved by the Northern Health institutional human re-
search ethics committee, the requirement for written
informed consent was waived.
Participants
Participants were consecutive patients enrolled in the
NA-HARP service who completed the Assessment of
Quality of Life (AQoL) at program enrolment.
Data collection
From 2007–2009, NA-HARP clinicians distributed AQoL
surveys by mail or directly to participants following their
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first assessment visit. Surveys were returned to the ser-
vice by reply paid post. Although the AQoL has been
translated into several languages, professional inter-
preters were also made available to assist participants
who spoke a language other than English and for those
with limited literacy.
Outcomes
The AQoL is a validated, multi-attribute utility instrument
designed to assess HRQoL that is sensitive to a range of
patient conditions and care models [18]. It measures five
dimensions: “Illness”, “independent living”, “social rela-
tionships”, “physical senses”, and “psychological well-
being”. These scales are scored as proportions on a
0.00–1.00 scale. Scores from the last four dimensions
are combined using a multiplicative model weighted
with community values to compute the utility index,
which is suitable for use in cost-utility analysis [18].
The utility scores range from −0.04 (HRQoL worse
than death), 0.00 (representing death equivalent states),
to 1.00 (full HRQoL), [19]. The AQOL is designed to
be self-administered taking an average of five to seven
minutes to complete. Population norms are available,
which allow the results to be interpreted relative to an
age-matched Australian population average [20, 21].
The published minimum important difference (MID) is
0.06 utilities [20].
Administrative data was used to classify patients’ pri-
mary reasons for enrolment into the NA-HARP service,
and the Charlson Comorbidity score (Charlson) at base-
line was calculated based on patients’ primary and sec-
ondary ICD-10 diagnoses codes from acute care
admissions prior to the patient’s enrolment in the service
[22]. Charlson weights were allocated to ICD-10 scores
using the algorithm developed by Quan e al. [23, 24].
Comorbidities were summarised as a Charlson Score
based on the original scoring weights published by
Charlson [24] the total Charlson score ranges between o
and a maximum of 24 points), the age-adjusted Charlson
Index was calculated adding one additional point for
each decade greater than 40 to 49 years.
At the end of the follow-up period, the number of
readmissions to acute care over the three years following
enrolment were obtained from the regional health ser-
vice’s administrative dataset and verified by audit of indi-
vidual patient medical records. Data was obtained on
both the number, duration and time (measured in years)
to these outcomes and acute care utilisation was mea-
sured as: emergency department (ED) readmission rate,
inpatient readmission rate, acute care length of stay and
total inpatient bed-days per annum. When calculating
acute health care utilisation rates over the three year
follow-up, the denominator was adjusted for deaths or
patients who were lost to follow-up.
Data analysis
Administrative and AQoL data were retrieved for pa-
tients enrolled in the service between September 2007
and September 2009. Continuous data were summarised
as means and standard deviations (SDs); categorical data
as frequencies and percentage, differences in proportions
were analysed with Chi-square (χ2) tests, differences in
continuous outcomes using T-tests. Differences in age
and Charlson score across the NA_HARP program
streams was analysed using ANOVA.
Mean AQoL scores were compared with published
population data across age deciles using Welch’s approxi-
mate t-tests to control for differences in data distributions
[24]. As Bartlett’s test for equal variances between groups
(according to primary health condition) showed statisti-
cally significant variation, and the AQoL utilities were not
normally distributed; the Kruskal-Wallis non-parametric
AVOVA was used to analyse differences in baseline AQoL
utilities and AQoL dimension scores according age group,
primary condition, service type and comorbidity scores. In
the absence of any known cut points, the AQoL dimen-
sions were entered as continuous variables into the model.
Statistical significance was set at p < 0.05.
Univariate logistic regression was used to assess
which factors were predictive of acute health care util-
isation over a three year follow-up period [25]. AQoL
scores were dichotomised at two standard deviations
below the population norm (ie: (<0.37/≥0.37) [20]. and
the Charlson Score was summarised as a four level or-
dinal variable (0 or 1, 2 or 3, 4 or 5 and 6 or more).
Multivariate logistic regression, using a forward step-
wise model, was used to assess whether lower AQoL
scores at enrolment were predictive of patients who re-
quired either an emergency department attendance or
an inpatient readmission within 12-months and three
years of enrolment after adjusting for age, and Charlson
Score. As there were significant differences in AQoL
scores according to Charlson score, an interaction term
was added into the model to test the interaction be-
tween these factors. Marginal analysis was used to test
the change in probability of acute care utilisation for
AQoL utility values (<0.37 versus ≥0.37) for each level
of the Charlson Score in the models [26]. The Hosmer
and Lemeshow statistic was used to test the goodness
of fit of the models [27] and the models’ predictive ac-
curacy were summarised using sensitivity, specificity
and positive and negative predictive values.
Data were analysed using STATA version 12, Statacorp
Texas USA [28].
Results
A consecutive sample of 1999 individuals enrolled in the
NA-HARP program between 2007 and 2009 had the
AQoL measured at enrolment into the program and were
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included in this study. The mean follow-up time for study
participants was 2.9 years (SD 0.55) and 180 (9 %) died
during follow-up. The mean age of participants was
63 years (range 18–101) and 54 % were male. Sixty-six
percent were born in a country other than Australia, 574
(29 %) spoke a language other than English, and 325
(16 %) required an interpreter for health care appoint-
ments (Table 1). Over half of the participants (1310, 66 %)
had an age adjusted Charlson Index of ≥ 3 and 448 (22 %)
had a Charlson Index of ≥ 7, indicating a substantial co-
morbidity burden.
Participants were enrolled from the following streams
within the NA-HARP program: diabetes 915 (46 %),
chronic respiratory disease 463 (23 %), cardiac disease
260 (13 %), peripheral vascular disease, and wound man-
agement services 181 (9 %) and aged care/complex case
management services 180 (9 %), (Table 1). Analysis of
covariance demonstrated that there were significant dif-
ferences in age (F = 70.5, df = 4, p < 0.001) and Charlson
Score (F = 17.5, df = 4, p < 0.001) across the program
streams. The respiratory, cardiac and diabetes streams
overall included younger adults with 142 patients aged
18–39 years, in contrast to five individuals in this age
group in the PVD/wound stream and none in the aged
care/complex case-management stream. The mean
Charlson scores across steams of care were: respiratory
2.5 (SD 2.5), cardiac 2.4 (SD .7) and diabetes 2.3 (SD
2.3), in comparison to the complex case management
3.2 (SD 3.0) and PVD 3.8 (SD 3.2) streams.
The mean HRQoL for all participants was AQoL 0.55
(SD 0.32, range −0.04 to 1). A HRQoL level considered
“worse than death” (AQoL < 0) was reported by 56 (3 %)
of participants. When compared with age-matched popu-
lation norms, study participants reported significantly
worse HRQoL. These differences exceeded the published
minimum important difference (MID) of 0.06 for the
AQoL for those aged 30 years and older (Table 2).
Table 3 shows the HRQoL of participants by primary
health condition and Charlson comorbidity score. There
were statistically significant differences between the dif-
ferent primary health conditions across the dimensions
of the AQoL and in overall AQoL utility scores. Partici-
pants with asthma, ischaemic heart disease or diabetes
(without peripheral vascular complications) had higher
overall HRQoL (AQoL utilities 0.57–0.62) than those
with CHF, COPD, peripheral vascular disease with com-
plications and complex wounds (AQoL utilities 0.40-
0.45) or those with aged care and complex needs (AQoL
utility 0.33). Participants with PVD reported the lowest
scores in the illness dimension of the AQoL (0.19), com-
pared to scores of 0.46 and 0.49 for asthma and IHD re-
spectively. Those in the aged care with complex needs
group reported the lowest scores on the independent liv-
ing dimension of the AQoL (0.49) compared to scores of
0.82 to 0.84 amongst those with asthma, IHD and dia-
betes. Differences between medical condition groups on
the social relationships, physical senses and psycho-
logical wellbeing dimensions were smaller, although the
differences between the lowest and highest scoring
groups did reach the MID.
Across all dimensions of the AQoL, HRQoL decreased
as the number of comorbidities increased, the differ-
ences between those scoring 0–1 on the Charlson and
those with six or more comorbidities on the Charlson
was 0.22 (p < 0.001) for overall HRQoL. Differences in
AQoL dimensions between those with the lowest (0–1)
and highest (≥6) Charlson scores reached the MID for:
the illness (difference 0.23, p < 0.001), independent living
(difference 0.25, p < 0.001), psychological well-being (dif-
ference 0.22, p < 0.001), and social relationships (differ-
ence 0.09, p < 0.001) dimensions.
Acute health care utilisation
Thirty-two percent (640) of participants presented to ED
during the first 12-months following enrolment and
1081 (54 %) presented at least once over three years. The
number of ED presentations per patient in the first year
ranged from 0–31 (mean 0.96 (SD 1.64)) and over three
years ranged from 0–52 per patient per year (mean 0.83
SD 2.17), (Table 1). Inpatient admission was required for
489 (25 %) of participants during the first 12-months fol-
lowing enrolment and for 841 (42 %) over three years.
The number of readmissions per patient ranged from 0
through to 20 (mean 0.50 (SD 1.41)) in the first year and
0 to 33 per patient per year over three years (mean 1.29
(SD 2.69)).
Additionally, each two point increase in the Charlson
score was associated with at 70 % increase in the odds of
ED attendance in the first 12 months post enrolment
(OR 1.70 (95 % CI: 1.56 to 1.86, p < 0.001) and almost
twice the odds of emergency inpatient admission (OR
1.98, 95 % CI: 1.80 to 2.18, p < 0.001). These differences
were sustained over the three years of follow-up with
each 2 point increase in the Charlson Score being asso-
ciated with a 40 % increase in the odds of ED attendance
(OR 1.40, 95 % CI: 1.30 to 1.51, P < 0.001), a 70 % in-
crease in the odds of non-elective inpatient admission
(OR 1.70, 95 % CI, 1.57 to 1.84, p < 0.001) and 64 % in-
crease in average annual beddays over three years (OR
1.64, 95 % CI 1.52 to 1.77, p < 0.001).
An AQoL utility score < 0.37 was associated with an
approximately two fold increase in emergency presenta-
tion (OR 1.96, 95 % CI, 1.61 to 2.3, p < 0.001) or in-
patient admission (OR 2.20, 95 % CI, 1.78 to 2.72, p <
0.001) over one and three years (OR 2.05, 95 % CI: 1.69
to 2.50, p < 0.001 and OR 2.36 95 % CI, 1.95 to 2.86, p <
0.001), (Table 4).
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Table 1 Participant characteristics
Participant characteristics N = 1999
Gender Male 1071 (54 %)
Female 928 (46 %)
Age Mean (SD) years 63 (14.4)
Range 18–101
Other household members Lived alone 366 (18 %)
Lived with family 1495 (75 %)
Lived with others 93 (5 %)
Unknown 45 (2 %)
Accommodation Type Private residence 1857 (93 %)
Supported accommodation 63 (3 %)
Residential aged care facility 22 (1 %)
Other 57 (3 %)
Primary health condition Diabetes 928 (46 %)
Chronic respiratory 463 (23 %)
Cardiac 277 (14 %)
Peripheral vascular disease/Diabetic Foot/Wounds 191 (10 %)
Neurological/Musculoskeletal/Functional status 140 (7 %)
Country of Birth Australia/New Zealand 877 (44 %)
United Kingdom/Ireland 77 (4 %)
Europe 724 (36 %)
Middle East 140 (7 %)
Other 173 (9 %)
Charlson Comorbidity Score 0/1 956 (48 %)
2/3 494 (25 %)
4/5 288 (14 %)
≥6 261 (13 %)
Charlson Index 0 99 (5 %)
1/2 589 (29.5 %)
3 /4 531 (26.7 %)
5/6 331 (16.6 %)
≥7 448 (22.4 %)
Service Type Diabetes 915 (46 %)
PVD/ Diabetic Foot/Wound 181 (9 %)
Respiratory 463 (23 %)
Asthma (215)
COPD (188)
Other Respiratory (60)
Cardiac 260 (13 %)
Ischaemic Heart Disease (136)
Chronic Heart Failure (122)
Aged care/complex psychosocial 180 (9 %)
Acute health care utilisation ED presentations - Mean (SD) 0.77 (1.87)
1 year following enrolment/patient Emergency inpatient admissions - Mean (SD) 0.50 (1.41)
Elective inpatient admissions - Mean (SD) 0.30 (0.99)
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Multivariate logistic regression models were con-
structed to determine whether HRQoL measured by the
AQoL predicted acute health care utilisation over one
and three years of follow-up (Table 5). To adjust for dif-
ferences across the NA_HARP program streams of care,
age, and Charlson score were included in the models.
Age was not predictive of acute health care utilisation in
either the one or three year multivariate models.
At one year, the Charlson score was predictive of both
ED attendances and inpatient admissions, while AQoL
utility score < 0.37 was not predictive after adjusting for
interactions with Charlson score (Table 4). Tests of mar-
ginal effects demonstrated that in both the model to pre-
dict ED attendance and to predict inpatient admission,
an AQoL score < 0.37 was a significant predictor for
those with Charlson scores of 4–5 but not for those with
Charlson Scores < 4 or >5. In contrast, an AQoL utility
score < 0.37 was predictive of both ED presentation
(Yes/No) and inpatients admissions (Yes/No) over three
years after adjusting for differences in age and any inter-
action between AQoL score and Charlson comorbidity
score (Table 5).
Discussion
This study found that both HRQoL and number of co-
morbidities (measured by the Charlson Score) were pre-
dictive of subsequent emergency department attendance
or inpatient admission over three years of follow-up. Pa-
tient reported HRQoL was partially related to burden of
comorbidities with lower HRQoL reported by those with
more comorbidities. At one year, number of comorbidi-
ties was a better predictor of emergency department re-
attendance and hospital readmission than HRQoL. It is
noteworthy that over longer periods of follow-up, patients’
self-reported HRQoL became an independent predictor of
the need for acute care services with statistically signifi-
cant increases in odds of emergency department re-
attendance or readmission across all levels of comorbidity
burden for those with AQol utility scores < 0.37. The
multivariate models had high levels of specificity for pa-
tients who would have a hospital re-attendance at one-
year (92 % specific) and three-years (97 % specific). The
positive predictive values were 60–65 % and false negative
rates of 20–28 % meaning that not all patients who would
subsequently have an acute care attendance would be
identified by these models.
These findings confirm previous studies using
disease-specific measures of quality of life that have
found an associated between quality of life and acute
care re-attendances. For patients with COPD and CHF
decrements in the physical functioning dimension of
HRQoL has been found be associated with a two to five
fold increase in the odds of hospital readmission [9–
11]. The association between poor self-reported quality
of life and adverse health outcomes may be related to
HRQoL being a proxy measure for disease severity,
functional decline and burden of comorbidities [34].
Although generic measures of HRQoL for older adults
(mean age 81 years) has also been found to predict sub-
sequent hospitalisation independent of disease severity
[29–34]. HRQoL measures may also capture underlying
psychological constructs such as overall satisfaction
with personal circumstances, levels of social support,
personal relationships and living environment, all fac-
tors which are acknowledged to be predictive of in-
creased ED attendances in frail older adults [31, 32].
Although there are some limitations to calculating co-
morbidities based on administrative data as there is the
possibility of under-reporting of comorbidities during
the hospital stay, the Charlson scale is established as
having reasonable predictive value for healthcare costs
and patient mortality [35]. The association between co-
morbidity burden, health-related quality of life and acute
health care utilisation found in this study confirms pre-
vious reports [36]. For COPD patients, comorbidity bur-
den is known to determine both elevated utilisation and
acute health care costs with those in the highest quartile
Table 1 Participant characteristics (Continued)
Total Bed-days - Mean (SD) 2.50 (8.10)
Over 3 years following enrolment/patient ED presentations - Mean (SD) 1.96 (3.62)
Emergency inpatient admissions - Mean (SD) 1.29 (2.70)
Total Bed-days - Mean (SD) 6.73 (16.6)
Table 2 Participants’ HRQoL (AQoL utility) compared with age-
adjusted population values
Age group Participants Populationa Statisticsb
N Mean SD N Mean SD
18–29 yearsc 38 0.84 0.20 1325 0.86 0.19 df = 37, p = 0.50
30–39 years 108 0.72 0.26 1681 0.84 0.21 df = 107, p < 0.001
40–49 years 211 0.61 0.30 1382 0.81 0.23 df = 210, p < 0.001
50–59 years 376 0.59 0.31 1295 0.80 0.24 df = 375, p < 0.001
60–69 years 543 0.59 0.30 1245 0.80 0.22 df = 542, p < 0.001
70–79 years 545 0.47 0.30 912 0.76 0.23 df = 544, p < 0.001
80+ yearsd 174 0.31 0.27 357 0.70 0.26 df = 173, p < 0.001
Notes:
a = Source: Hawthorne, Korn & Richardson (2013)
b = Independent t-test
c = Includes 6 cases <20 years
d = The population was restricted to those 80 to 85 years
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for comorbidities consuming 63 % of the acute costs for
this condition [37, 38]. For patients with diabetes those
with three or more diabetes-related systemic complica-
tions had two-fold higher acute care costs compared to
those without complications [39].
The main limitations of this study was that it used a
sample of patients enrolled in the disease management
programs who were willing to give verbal consent to
complete the AQoL questionnaire, therefore there may
be some bias in the selection of patients included in this
analysis. Administrative data as used to obtain acute care
utilisation data from the health service that provided the
chronic disease management program in which patients
were enrolled. It is possible that some patients may have
been admitted elsewhere for acute care management
during the three years of follow-up.
This study confirms previous research that across a
wide range of conditions, adults with chronic disease re-
port lower health-related quality of life than aged
matched that population based samples [40]. The magni-
tude of decrement in HRQoL varied across the different
medical conditions, with the highest HRQoL reported by
younger adults attending asthma, ischaemic heart dis-
ease program and the lowest quality of life reported by
those requiring aged care services and those being man-
aged for complicated peripheral vascular disease. These
differences reflect the impact of both the primary health
condition and the impact of comorbidities, the greatest
Table 3 Differences in HRQoL (AQoL) dimensions across primary condition and Charlson comorbidity scores
Mean (SD) AQoL dimension scoresa AQoL
N Ill IL SR PS PW utility
Primary health
condition
Asthma 215 0.46 (0.30) 0.82 (0.26) 0.85 (0.22) 0.93 (0.11) 0.83 (0.17) 0.61 (0.30)
COPD/other 248 0.39 (0.27) 0.68 (0.30) 0.79 (0.23) 0.88 (0.12) 0.80 (0.19) 0.45 (0.27)
Chronic Heart
Failure
122 0.28 (0.24) 0.68 (0.32) 0.79 (0.24) 0.87 (0.15) 0.78 (0.20) 0.45 (0.31)
Ischaemic Heart
Disease
136 0.49 (0.23) 0.82 (0.26) 0.84 (0.20) 0.91 (0.10) 0.82 (0.15) 0.57 (0.27)
Diabetes 915 0.34 (0.25) 0.84 (0.26) 0.88 (0.21) 0.93 (0.10) 0.82 (0.20) 0.62 (0.31)
Peripheral Vascular
Disease
151 0.19 (0.22) 0.63 (0.33) 0.76 (0.27) 0.86 (0.15) 0.76 (0.22) 0.40 (0.32)
Wound care 30 0.43 (0.29) 0.60 (0.37) 0.78 (0.22) 0.88 (0.15) 0.83 (0.16) 0.43 (0.33)
Aged Care 180 0.30 (0.25) 0.49 (0.33) 0.72 (0.29) 0.86 (0.14) 0.79 (0.19) 0.33 (0.27)
Kruskal-Wallis
ANOVA Test
χ2 = 141.6 p <
0.001
χ2 = 252.1 p <
0.001
χ2 = 132.2 p <
0.001
χ2 = 102.4 p <
0.001
χ2 = 29.52 p <
0.001
χ2 = 208.9 p <
0.001
Statistics 0/1 955 0.43 (0.27) 0.84 (0.25) 0.86 (0.21) 0.92 (0.11) 0.83 ( 0.18) 0.61 (0.30)
Charlson
Score
2/3 494 0.32 (0.24) 0.76 (0.29) 0.84 (0.23) 0.91 (0.11) 0.81 (0.20) 0.54 (0.31)
4/5 288 0.28 (0.23) 0.69 (0.31) 0.80 (0.25) 0.89 (0.12) 0.80 (0.19) 0.48 (0.31)
≥6 262 0.23 (0.24) 0.59 (0.35) 0.77 (0.27) 0.87 (0.15) 0.77 (0.21) 0.39 (0.31)
Kruskal-Wallis
ANOVA Test
χ2 = 182.8 p <
0.001
χ2 = 153.4 p <
0.001
χ2 = 45.5 p <
0.001
χ2 = 40.3 p <
0.001
χ2 = 24.3 p <
0.001
χ2 = 118.9 p <
0.001
a = Ill: Illness; IL: Independent living; SR: Social relationships; PS: Physical senses; PW: Psychological wellbeing; SD = Standard Deviation
Table 4 Univariate logistic regression models: predicting acute
health care utilisation
Predictor OR 95 % CI P Value
ED presentation with 1 year
AQOL utility score <0.37 1.96 1.61 to 2.3 <0.001
Charlson Score 1.70 1.56 to 1.86 <0.001
Age group 1.27 1.13 to 1.44 <0.001
Inpatient admission within 1 year
AQOL utility score <0.37 2.20 1.78 to 2.72 <0.001
Charlson Score 1.98 1.80 to 2.18 <0.001
Age group 1.52 1.33 to 1.73 <0.001
ED presentations within 3 years
AQOL utility score <0.37 2.05 1.69 to 2.50 <0.001
Charlson Score 1.72 1.57 to 1.88 <0.001
Age group 1.26 1.12 to 1.41 <0.001
Inpatient admission within 3 years
AQOL utility score <0.37 2.36 1.95 to 2.86 <0.001
Charlson Score 2.06 1.88 to 2.27 <0.001
Age group 1.64 1.46 to 1.85 <0.001
Age group: ordinal variable: 18–50, 51–70, 71–84, and ≥85 years
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Table 5 Multivariate logistic regression models: predicting acute health care utilisation
ED presentation with 1 year ED presentations within 3 years
Predictor OR 95 % CI P Value Predictor OR 95 % CI P Value
AQOL utility score <0.37 1.35 0.95 to 1.91 0.094 AQOL utility score <0.37 1.58 1.16 to 2.13 0.003
Charlson Score (2–3) 1.48 1.09 to 2.00 0.011 Charlson Score (2–3) 1.71 1.32 to 2.23 <0.001
Charlson Score (4–5) 2.39 1.66 to 3.45 <0.001 Charlson Score (4–5) 1.96 1.39 to 2.76 <0.001
Charlson Score (≥6) 4.91 3.26 to 7.40 <0.001 Charlson Score (≥6) 6.36 3.96 to 10.20 <0.001
Correct classification: 70.0 %; Hosmer and Lemeshow χ2 (9) = 11.53, p = 0.117. Correct classification: 62.09 %; Hosmer and Lemeshow χ2 (8) = 34.00, p < 0 .00
Change in probability for AQoL utility score <0.37 at each level of the Charlson Score
Coeff 95 % CI P Value Coeff 95 % CI P Value
Charlson Score 2–3*AQOL 0.53 -0.11 to 0.12 0.106 Charlson Score 2–3*AQOL 0.11 0.04 to 0.19 0.003
Charlson Score 4–5*AQOL 0.19 1.00 to 0.28 <0.001 Charlson Score 4–5*AQOL 0.19 0.10 to 0.28 <0.001
Charlson Score (≥6)*AQOL 0.11 -0.12 to 0.22 0.079 Charlson Score≥ 6*AQOL 0.12 0.01 to 0.23 0.040
Sensitivity 24.85 % False Negative 75.15 % Sensitivity 69.7 % False Negative 30.3 %
Specificity 92.12 % False Positive 7.88 % Specificity 52.2 % False Positive 47.8 %
Positive Predictive value 60.30 % False Positive 39.70 % Positive Predictive value 63.3 % False Positive 36.8 %
Negative Predictive value 71.8 % False Negative 28.20 % Negative Predictive value 59.4 % False Negative 40.6 %
Emergency Inpatient admissions within 1 year Inpatient admission within 3 years
Predictor OR 95 % CI P Value Predictor OR 95 % CI P Value
AQOL utility score <0.37 1.25 0.82 to 1.91 0.299 AQOL utility score <0.37 1.67 1.21 to 2. 30 0.002
Charlson Score (2–3) 1.57 1.10 to 2.24 0.012 Charlson Score (2–3) 1.99 1.51 to 2.63 <0.001
Charlson Score (4–5) 2.79 1.87 to 4.18 <0.001 Charlson Score (4–5) 2.62 1.85 to 3.73 <0.001
Charlson Score (≥6) 6.30 4.11 to 9.66 <0.001 Charlson Score (≥6) 8.76 5.59 to 13.73 <0.001
Correct classification: 77.5 %; Hosmer and Lemeshow χ2 (8) = 5.71, p = 0.456 Correct classification: 68.2 %; Hosmer and Lemeshow χ2 (8) = 4.95, p = 0 .666
Change in probability for AQoL utility score <0.37 at each level of the Charlson Score
Coeff 95 % CI P Value Coeff 95 % CI P Value
Charlson Score 2–3*AQOL 0.27 -0.13 to 0.08 0.316 Charlson Score 2–3*AQOL 0.11 0.04 to 0.18 0.003
Charlson Score 4–5*AQOL 0.16 0.08 to 0.25 <0.001 Charlson Score 4–5*AQOL 0.19 0.96 to 0.29 <0.001
Charlson Score (≥6)*AQOL 0.08 -0.03 to 0.19 0.147 Charlson Score≥ 6*AQOL 0.11 -0.01 to 0.23 0.066
Sensitivity 18.2 % False Negative 81.8 % Sensitivity 44.3 % False Negative 55.7 %
Specificity 96.8 % False Positive 3.2 % Specificity 86.2 % False Positive 13.8 %
Positive Predictive value 65.0 % False Positive 35.0 % Positive Predictive value 70.1 % False Positive 29.9 %
Negative Predictive value 78.5 % False Negative 21.5 % Negative Predictive value 67.9 % False Negative f 32.1 %
Interaction between HRQoL measured by AQoL and Charlson Score not significant, adjusted by age Not significant
* = Interaction between Charlson Score and AQoL score in the multivariate model
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impacts being demonstrated in the illness and independ-
ent living dimensions of the AQoL. Consistent with pre-
vious studies, these findings demonstrate that as the
population ages and the prevalence of chronic disease
increases that the prevalence of individuals reporting
lower HRQoL is also likely to increase [40]. Policy
makers can therefore anticipate increased demand for
both medical management of chronic disease but also
importantly increased demand for allied health and sup-
portive care services to assist individuals to adjust to and
manage the impact these conditions have on their per-
sonal well-being, functional capacity and personal inde-
pendence [12, 13, 33, 39].
Conclusion
Measures of HRQoL and burden of comorbidities meas-
ure separate risk factors for hospital readmission that
also interact with each other. These findings indicate
that clinicians evaluating patients’ need for ambulatory
chronic disease management programs should take into
consideration both their comorbidity burden and the pa-
tients’ perception of the impact of their condition(s) on
their HRQoL. To maximise their benefits ambulatory
disease management programs should initially focus on
optimisation of medical management of chronic disease
and associated comorbidities, but subsequently the focus
should switch to strategies that enhance health inde-
pendence and raise HRQoL over the longer term.
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